{"name":"SolAeroMed Inc.","slug":"solaeromed-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxPSXpwLURSaVdqVUlBWFFEcXRDYjBaNnhBdEpPVmZtdHdXQjF2WlNyMXJwdWx5MHlUQ3pPVEIwd0lIYnNOWFpsSlg5aHg2QmZncC1kdWZEdHNPUkp1ckJYcWQ5S3ZjVzlrd3l3d0tZZnFVWnh3SHVzb29GMTJEYXQ2ZzkyYTRLT0s5TTdWSDc5WjhrcE0tVkRHcU02UDJ4bDZqbVFiSV9TNV9qWFQ5ODhweXZfOFkwNi04QnNCUUZZTHlsa2RLVWsxYkFlQnI3ZGRWS1dLN1ZLb0o0cVMtT1dhRVk0Y2wzWFRoR1pUT2pJQ0FUcnQ2eFZLOUJWd01FT2YyaDBrR1hiTFlkbmViNXhCYUhRMjMyejZZdU85OU9YcGZ4NUN6M2s5OWRPRjFyY2lPeEdmY2o5clZsWFZVSzRvVzhXOU1yTk5NVlE?oc=5","date":"2026-04-07","type":"pipeline","source":"Barchart.com","summary":"Non-Cystic Fibrosis Bronchiectasis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farmaceutici, SolAeroMed - Barch","headline":"Non-Cystic Fibrosis Bronchiectasis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, Astr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxPb0tiLTlxWUZNaHpRQ1puVTFqbnRpWHVranVyV2huU3dYRlNrbVlSSmZhellxZG1UVFYtS3piYVpoQUV6RGJyandKZzBkaUIwVE1NQ1oyQVJsdjhOX2V3NFlwTTZ2RTk4SnAxT0kyUWdwSkdvZ0QtUVJIVkpGS0ttc2wtMWM2UTNlcHZ2Z1JzcEJzb1hyVHlWWDVuUXhhbERsUHl4cVV6SnlTZmJhczRsV3MyZldOYm9JODZ0Ti1EWTVibjIwMnJTa1l1N09fc1JMdVpUU0JCQ0ZmVV9XMnhOcUJVQkVHakNIRmlYbEVpN0NEZVBWTVVsOE0wWncwTjJJYi1DbnBWZGdwa0YyM1pRbGh6NXZ6bjY2bDRjMnBFcEtPZEF5?oc=5","date":"2026-03-20","type":"pipeline","source":"Barchart.com","summary":"Cystic Fibrosis Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farmaceutici, SolAeroMed - Barchart.com","headline":"Cystic Fibrosis Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Insmed, AstraZeneca, Zambion, The Mar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOcFlvUEYwSFdvT0JPZ1hiYlVEWERxZURGTk16d0ZlNnhhSUw5d2M4M3JSWHZTLWdMSE1mMTh4QzNxbXY5U1ZUVVFPMnl0M19mX082TXRjMmlqT1dPZXZ3aXFaemRzTnZmRWlJd2ZBQXRGaGtaWlJ1ZF9MR0VUckFnalZRWmVaYjJUZHJWa21R?oc=5","date":"2024-09-18","type":"pipeline","source":"C&EN","summary":"R&D for long COVID is collapsing - C&EN","headline":"R&D for long COVID is collapsing - C&EN","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}